Skip to main content Back to Top
Advertisement

7/25/2022

Labetalol Tablets

Products Affected - Description

    • Labetalol tablet, Alvogen, 100 mg, bottle, 100 count, NDC 47781-0552-01 - discontinued
    • Labetalol tablet, Alvogen, 100 mg, bottle, 500 count, NDC 47781-0552-05 - discontinued
    • Labetalol tablet, Alvogen, 200 mg, bottle, 100 count, NDC 47781-0553-01 - discontinued
    • Labetalol tablet, Alvogen, 200 mg, bottle, 500 count, NDC 47781-0553-05 - discontinued
    • Labetalol tablet, Alvogen, 300 mg, bottle, 100 count, NDC 47781-0554-01 - discontinued
    • Labetalol tablet, Sandoz, 100 mg, bottle, 100 count, NDC 00185-0010-01 - discontinued
    • Labetalol tablet, Sandoz, 100 mg, bottle, 500 count, NDC 00185-0010-05 - discontinued
    • Labetalol tablet, Sandoz, 200 mg, bottle, 100 count, NDC 00185-0117-01 - discontinued
    • Labetalol tablet, Sandoz, 200 mg, bottle, 500 count, NDC 00185-0117-05 - discontinued
    • Labetalol tablet, Sandoz, 300 mg, bottle, 100 count, NDC 00185-0118-01 - discontinued
    • Labetalol tablet, Sandoz, 300 mg, bottle, 500 count, NDC 00185-0118-05 - discontinued

Reason for the Shortage

    • Alvogen has discontinued labetalol tablets.
    • Major has labetalol tablets available.
    • Par has labetalol tablets available.
    • Sandoz discontinued labetalol presentations in January 2022.
    • Teva has labetalol tablets available.
    • Zydus has labetalol tablets available.

Available Products

    • Labetalol tablet, Major, 200 mg, unit-dose blister pack, 100 count, NDC 00904-7110-61
    • Labetalol tablet, Par Pharmaceuticals, 100 mg, bottle, 100 count, NDC 49884-0122-01
    • Labetalol tablet, Par Pharmaceuticals, 200 mg, bottle, 100 count, NDC 49884-0123-01
    • Labetalol tablet, Par Pharmaceuticals, 300 mg, bottle, 100 count, NDC 49884-0124-01
    • Labetalol tablet, Teva, 100 mg, bottle, 100 count, NDC 00591-0605-01
    • Labetalol tablet, Teva, 100 mg, bottle, 500 count, NDC 00591-0605-05
    • Labetalol tablet, Teva, 200 mg, bottle, 100 count, NDC 00591-0606-01
    • Labetalol tablet, Teva, 200 mg, bottle, 500 count, NDC 00591-0606-05
    • Labetalol tablet, Teva, 300 mg, bottle, 100 count, NDC 00591-0607-01
    • Labetalol tablet, Zydus, 100 mg, bottle, 100 count, NDC 68382-0798-01
    • Labetalol tablet, Zydus, 100 mg, bottle, 500 count, NDC 68382-0798-05
    • Labetalol tablet, Zydus, 200 mg, bottle, 100 count, NDC 68382-0799-01
    • Labetalol tablet, Zydus, 200 mg, bottle, 500 count, NDC 68382-0799-05
    • Labetalol tablet, Zydus, 300 mg, bottle, 100 count, NDC 68382-0800-01
    • Labetalol tablet, Zydus, 300 mg, bottle, 500 count, NDC 68382-0800-05

Updated

Updated July 25, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 18, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT